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Antidiarrhoeal, antisecretory and antispasmodic
activities of Matricaria chamomilla are mediated
predominantly through K+-channels activation
Malik Hassan Mehmood1*, Siraj Munir1†, Uzair Ali Khalid1†, Mudassir Asrar2† and Anwarul Hassan Gilani1†
Abstract
Background: Matricaria chamomilla commonly known as “Chamomile” (Asteraceae) is a popular medicinal herb
widely used in indigenous system of medicine for a variety of ailments. However, there is no detailed study
available showing its effectiveness in hyperactive gut disorders like, abdominal colic and diarrhoea. This study was
designed to determine the pharmacological basis for the folkloric use of Matricaria chamomilla in diarrhoea.
Methods: The crude aqueous-methanolic extract of Matricaria chamomilla (Mc.Cr) was studied for its protective ef-
fect in mice against castor oil-induced diarrhoea and intestinal fluid accumulation. The isolated rabbit jejunum
was selected for the in-vitro experiments using tissue bath assembly coupled with PowerLab data acquisition system.
Results: Oral administration of Mc.Cr to mice at 150 and 300 mg/kg showed marked antidiarrhoeal and antisecretory
effects against castor oil-induced diarrhoea and intestinal fluid accumulation, simultaneously, similar to the effects of
cromakalim and loperamide. These effects of plant extract were attenuated in animals pretreated with K+ channel an-
tagonist, glibenclamide (GB) or 4-aminopyridine (4-AP). When tested in isolated rabbit jejunum, Mc.Cr caused a dose-
dependent (0.3-3 mg/ml) relaxation of spontaneous and low K+ (25 mM)-induced contractions, while it exhib-
ited weak inhibitory effect on high K+ (80 mM). The inhibitory effect of Mc.Cr on low K+-induced contractions
was partially inhibited in the presence of GB, while completely blocked by 4-AP. Cromakalim, an ATP-sensitive K+
channel opener, caused complete relaxation of low K+-induced contractions with little effect on high K+. Pretreat-
ment of tissues with GB blocked the inhibitory effects of cromakalim on low K+, while the presence of 4-AP
did not alter the original effect. Verapamil, a Ca++ channel antagonist, caused complete relaxation of both
low and high K+-induced contractions with similar potency. The inhibitory effect of verapamil was insensitive
to GB or 4-AP. When assessed for Ca++ antagonist like activity, Mc.Cr at high concentrations caused rightward
shift in the Ca++ concentration-response curves with suppression of the maximum response, similar to the ef-
fect of verapamil, while cromakalim did not show similar effect.
Conclusions: This study indicates that Matricaria chamomilla possesses antidiarrhoeal, antisecretory and
antispasmodic activities mediated predominantly through K+-channels activation along with weak Ca++
antagonist effect.
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Background
Matricaria chamomilla L. (synonym: Matricaria recutita)
commonly known as Chamomile or German Chamomile,
belongs to family Asteraceae [1]. Multiple species of
Chamomile are spread over Europe, North-west Asia,
North America, North Africa and the temperate regions
of Asia [2,3]. In Pakistan, it is known as babuna or piun-
phulli and grows naturally in highlands of Balochistan
such as, Hanna valley, Maslakh range, Muslimbagh, Kalat,
Nushki, Kharan, Chaman and Ziarat. This plant is widely
recognized and is more popular in the western culture for
its diverse medicinal uses [1,4]. Since ancient times and in
accordance with the references written by Hippocrates,
Galen and Asclepius, its different parts including flowers,
roots and oil have been used to treat variety of ailments [5].
Chamomile as a whole plant has been used traditionally
in different forms for the treatment of multiple medical
complaints such as, common cold, bronchitis, gastrointes-
tinal spasms, epilepsy, hypertension, neuralgia, toothache,
dysmenorrhea, eczema, impetigo, indigestion, colic and
diarrhea [1,4-9]. Its flowers are also used as carminative
and antipyretic, while its oil has been used in rheumatism,
flatulence and colic [10]. In addition, this plant had a very
long history of its medicinal use in ancient Egypt, Greece
and Rome [11]. Chamomile is also one of the effective in-
gredients of several traditional formulations in the Unani
and Homeopathy systems of medicine [11-15].
Phytochemical studies revealed the presence of alpha-
bisabolol, cis-spiroethers sesquiterpenes (anthecotulid),
cadinene, farnesene, furfural, spathulenol, and proazulene
(matricarin and matricin) as plant constituents [5,16].
In addition, Chamomile has also been found to possess
around 8% of flavone glycosides (apigenin 7-glycoside and
its 6’-acetylated derivative) and flavonols (luteolin gluco-
sides, quercetin glycosides, and isohamnetin); 10% of
mucilage polysaccharides; 0.3% of choline and 0.1% of
coumarins (umbelliferone and its methyl ether, herniarin).
The presence of tannin in chamomile has also been de-
tected less than 1% [17-19].
Pharmacological investigations showed that Matricaria
chamomilla possesses antiinflammatory [20], antispas-
modic [21,22], antibacterial [23], digestive [24], antioxi-
dant and antidiabetic [25,26] activities. However, there is
little evidence available to its medicinal use in diarrhoea.
This study has been planned to explore the scientific
basis for the medicinal use of Matricaria chamomilla in
hyperactive gut disorders, like diarrhoea and abdominal
spasms using different in vivo and in vitro assays.
Methods
Plant material and extraction
The aerial parts of Matricaria chamomillla L. collected and
identified by Dr. Mudassir Asrar (University of Balochistan,
Quetta, Pakistan). A voucher specimen # BGUOB-187
was deposited in the herbarium of Department Botany,
University of Balochistan. The dried plant material weigh-
ing 400 g was used for extraction and soaked in 70%
methanol for three days, with occasional shaking. The
soaked material was filtered through a muslin cloth and
then through a Whatman qualitative grade 1 filter paper.
This procedure was repeated three times and the com-
bined filtrate was evaporated using rotary evaporator to
get the final aqueous-methanolic extract of Matricaria
chamomillla (Mc. Cr), yielding 15% w/w [27].
Drugs and animals
Potassium chloride, verapamil hydrochloride, loperamide
and 4-aminopyridine were purchased from Sigma Chemicals
Co, St Louis, MO, USA. Cromakalim and glibenclamide
were purchased from Tocris, Ellisville, MO and RBI
Chemicals Co, Natick, MA, USA respectively. Castor oil
was purchased from Karachi chemical industries (Pvt.)
Ltd. F/25 S. I. T. E., Karachi (Pakistan). All chemicals used
were of the analytical grade available and solubilized in
distill water/saline except cromakalim and glibenclamide,
which were dissolved in 10% DMSO to prepare stock so-
lutions. The vehicle used for solubilization was found inert
on isolated tissue preparations in control experiments.
Stock solutions of all chemicals were made fresh in nor-
mal saline on the day of the experiment.
BALB/c mice (weighing 20–25 g) and locally bred rab-
bits (weighing 1–1.5 kg) of both genders, were housed at
the Animal House of Aga Khan University under con-
trolled environmental conditions (23–25°C). The animals
were fasted for 12–16 h before the experiment, whereas
they were given tap water and standard diet routinely. Ex-
periments were performed with the rulings of the Institute
of Laboratory Animal Resources, Commission on Life
Sciences, National Research Council [28] and also in ac-
cordance with Institutional guidelines. The study proto-
col (016-ECACU-BBS-13) was approved by the Ethics
Committee for Animal Care and Use (ECACU) of the
Aga Khan University.
In-vivo assays
Antidiarrhoeal activity
Mice (20–25 g, n = 78) of either gender were fasted
for 12–16 h before the experiment. The animals were
housed in individual cages and divided into 13 groups,
each containing six animals. The first group received sa-
line along with solubilizing vehicle (10 ml/kg) orally (p.o.),
acted as negative control. The group 2 and 3 received cro-
makalim (10 mg/kg, p.o.) and loperamide (10 mg/kg, p.o.),
respectively, serving as the positive controls. The group 4
and 5 received different doses (150 and 300 mg/kg, p.o.)
of Mc. Cr. Of the remaining eight groups, the group
6, 8, 10 and 12 were pretreated with glibenclamide (GB,
3 mg/kg, i.p.) and the group 7, 9, 11 and 13 were
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administered 4-aminopyridine (4-AP, 5 mg/kg, i.p.) 30 min
before re-administration of cromakalim, loperamide or
Mc. Cr. After 1 h of respective treatments, each animal re-
ceived 10 ml/kg castor oil orally through a feeding needle.
After 5 h, the mouse cages were individually inspected for
mean defecation per group, mean number of wet feces
and mean number of dry feces. The percentage protection
in each group was calculated as, (mean number of dry
feces/mean defecation) × 100 [29].
Intestinal fluid accumulation
By following previously described method with slight
modification [30], 12–16 h fasted mice (weighing 20–25 g,
n = 84) of either gender were housed in cages in fourteen
equally divided groups (n = 6). The first two groups re-
ceived saline in a solubilizing vehicle (10 ml/kg, p.o.) and
acted as negative controls. The animals in group 3 and 4
were administered cromakalim (10 mg/kg) and lopera-
mide (10 mg/kg) intraperitoneally (i.p.), respectively, using
a detachable U-100 insulin syringe with a 25 G × 1″
(0.50 × 25 mm) needle, as the positive controls. The group
5 and 6 were treated with increasing doses of the plant
extract (150 and 300 mg/kg, p.o.). The group 7, 9, 11
and 13 were pretreated with glibenclamide (GB, 3 mg/kg,
i.p.), while the group 8, 10, 12 and 14 were pretreated
4-aminopyridine (4-AP, 5 mg/kg, i.p.) 30 min before
re-administration of cromakalim, loperamide or Mc. Cr.
After 1 h of the respective treatments, each animal re-
ceived castor oil (10 ml/kg. p.o.), except the animals in
group one. All the animals were sacrificed 30 min later by
cervical dislocation and the intestine was dissected out
carefully, not allowing any intestinal fluid to leak out, and
weighed. The results were expressed as (Pi/Pm) × 1000
whereas, Pi is the weight of the intestine and Pm is the
weight (in g) of the animal.
Acute toxicity test
A total of 40 Balb/c mice (20–25 g) of either sex were
equally divided into four groups. The test was performed
using increasing doses of the crude extract of the Matri-
caria chamomillla (1, 3 and 5 g/kg) given orally in
10 ml/kg control vehicle to different animals serving as
the test groups. Another group of mice was administered
control vehicle (10 ml/kg) orally as the negative control.
The animals were allowed food and water ad libitum
and kept under regular observation for 6 h to observe
their piloerection, changes in exploratory behavior and
blindness, while lethality was monitored up to 24 h.
In-vitro experiments
Antispasmodic activity
The spasmolytic activity of the test material was studied
by using isolated rabbit jejunum preparations [31]. Re-
spective segments of 2 cm in length were suspended
individually in 10 ml tissue baths containing Tyrode’s so-
lution, aerated with a mixture of 95% oxygen and 5%
carbon dioxide (carbogen) and maintained at 37°C using
thermo-circulator. The composition of the Tyrode’s so-
lution in mM was: KCl 2.68, NaCl 136.9, MgCl2 1.05,
NaHCO3 11.90, NaH2PO4 0.42, CaCl2 1.8 and glucose
5.55 (pH 7.4). Intestinal responses were recorded isotonic-
ally using Bioscience Transducers coupled with PowerLab
data acquisition system (ADInstruments, Sydney, Australia).
Each tissue was allowed to equilibrate for at least 30 min
before the addition of any drug and then stabilized with a
sub-maximal concentration of acetylcholine (ACh, 0.3 μM)
and the bath fluid was subsequently replaced with normal
Tyrode’s solution before starting the experiment.
The myorelaxant effect of the plant extract was assessed
on spontaneously contracting isolated rabbit jejunum. For
elucidation of the possible mechanism of spasmolytic ef-
fect, low K+ (25 mM) and high K+ (80 mM) were used to
depolarize the isolated tissues which in turn produced sus-
tained contractions, which are considered useful for de-
termining the different inhibitory mechanisms like, K+
channel activation [32] and Ca++channel blockade
[33], respectively. The test material was then added in
a cumulative fashion to obtain concentration-dependent
inhibitory responses. The relaxation of isolated tissue
preparations was expressed as percent of the control
response mediated by added low or high K+-induced
concentrations.
To know the nature of K+ channels involved in the in-
hibitory effect of the test material, the spasmolytic effect
of the test material was studied on low K+-induced con-
tractions in the absence and presence of glibenclamide
(GB), an ATP-dependent K+-channel blocker [34] or 4-
aminopyridine (4-AP), a voltage-dependent K+ channel
blocker [35].
To confirm the presence of Ca++ antagonist like activity
in the test material, the tissue were allowed to stabilize in
normal Tyrode’s solution, which was then replaced with
Ca++-free Tyrode’s solution containing EDTA (0.1 mM)
for 30 min in order to chelate Ca++ from the environment
and the tissues [36]. This solution was further replaced
with K+-rich and Ca++-free Tyrode’s solution with follow-
ing constitution (mM): KCl 50, NaCl 91.04, MgCl2 1.05,
NaHCO3 11.90, NaH2PO4 0.42, glucose 5.55 and EDTA
0.1. After an incubation period of 30 min in normal
Tyrode’s solution, the concentration-response curves
(CRCs) of Ca++ were constructed. When the control CRCs
of Ca++ were found super imposable (usually after two cy-
cles), then the tissue was pre-incubated with test sub-
stance for 60 min to confirm the possible Ca++ antagonist
like activity [37]. In the presence of different concentra-
tions of the test material, the CRCs of Ca++ were recon-
structed. Non-parallel rightward shift with suppression
of the maximum response of Ca++ in the presence of
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test substance indicates Ca++ antagonist-like antispas-
modic activity.
Statistical analysis
All the data expressed are mean ± standard error of mean
(s.e.m., n = number of experiments) and the median effect-
ive concentrations (EC50 values) with 95% confidence
intervals (CI). The concentration-response curves were
analyzed by non-linear regression (Graph-PAD program,
Graph-PAD, San Diego, CA, USA). Unpaired t-test or
One-way ANOVA followed by Dunnett’s test was used for
antidiarrhoeal and intestinal fluid accumulation assays.
Probability of less than 0.05 was considered significantly
different.
Results
Effect of Matricaria chamomillla on castor oil-induced
diarrhoea in mice
Oral administration of Matricaria chamomillla exhibited
dose-dependent inhibitory effect against castor oil-induced
diarrhoea in mice by producing 41.4 and 61.9% protection
at the respective doses of 150 and 300 mg/kg. The positive
controls of cromakalim and loperamide caused 65.2 and
77.2% protection, respectively, while saline treated group
showed only 12.4% protection. When the effect of Mc. Cr
was restudied in mice pretreated with GB or 4-AP, it
was attenuated to 34.1 and 22.5% vs. 41.4% (effect of
Mc. Cr without antagonist), respectively, at 150 mg/kg,
and decreased to 44.9 and 29.8% vs. 61.9% at 300 mg/kg.
Similarly, the effect of cromakalim was significantly re-
duced to 25.6% vs. 65.2% when reproduced in the pres-
ence of GB, while remained devoid of any significant
change in the presence of 4-AP. Loperamide did not show
sensitivity to GB or 4-AP (Table 1).
Further to assess its inhibitory effect on intestinal se-
cretions, Mc. Cr was studied on castor oil-induced intes-
tinal fluid accumulation in mice.
Effect of Matricaria chamomillla on castor oil-induced
intestinal fluid accumulation in mice
In enteropooling assay, castor oil administration caused
a substantial increase (p < 0.001) of fluid accumulation
in mice with (Pi/Pm) × 1,000 value of 150 ± 8.0 when
compared with saline administered group (105 ± 4.5).
The administration of Mc. Cr to mice produced a signifi-
cant (p < 0.001) reduction in castor oil-induced fluid accu-
mulation at 150 and 300 mg/kg with respective (Pi/Pm) ×
1,000 values of 96 ± 4.6 and 90 ± 1.2, similar to the effects
cromakalim (84 ± 2.7) and loperamide (75 ± 3.2) at the
doses of 10 mg/kg, respectively. When the inhibitory po-
tential of Mc. Cr on castor oil-induced fluid accumulation
was restudied in mice pretreated with GB or 4-AP, it was
attenuated with resultant values of 105 ± 2.4 and 112 ± 4.9
vs. 96 ± 4.6 (effect of Mc. Cr without antagonist), respect-
ively at 150 mg/kg, and also decreased with respective
values of 108 ± 1.5 and 119 ± 1.2 vs. 90 ± 1.2 at 300 mg/kg.
Similarly, the effect of cromakalim was significantly re-
duced in the presence of GB with resultant value of 135 ±
Table 1 Antidiarrhoeal effect of the crude extract of Matricaria chamomilla (Mc.Cr) against castor oil (10 mL/kg)-induced
diarrhoea in mice without and with pre-administration of 3 mg/kg glibenclamide (GB) or 5 mg/kg 4-aminopyridine (4-AP)
Group no. Treatment Dose (mg/kg) Mean defecation/group Mean no. of wet
feces/group
Mean no. of dry
feces/group
% Protection
1 Castor oil (10 mL/kg) + Saline 10 8.92 ± 1.24 7.81 ± 2.11 1.11 ± 0.21 12.4%
2 Castor oil + Cromakalim 10 6.67 ± 0.90# 2.32 ± 0.40### 4.35 ± 1.70# 65.2%
3 Castor oil + Loperamide 10 4.70 ± 0.90### 1.07 ± 0.30### 3.63 ± 0.90# 77.2%
4 Castor oil + Mc.Cr (p.o) 150 5.47 ± 1.37** 3.20 ± 0.50** 2.27 ± 0.58* 41.4%
5 Castor oil + Mc.Cr (p.o.) 300 4.20 ± 0.29*** 1.61 ± 0.92*** 2.59 ± 0.33* 61.7%
Effect of different treatments in the presence of GB or 4-AP
6 Castor oil + GB + Cromakalim 3 + 10 7.40 ± 0.95$ 5.50 ± 0.70$$$ 1.90 ± 0.85$$ 25.6%
7 Castor oil + 4-AP + Cromakalim 5 + 10 6.70 ± 0.50 2.80 ± 0.75 3.90 ± 0.35$ 58.2%
8 Castor oil + GB + Loperamide 3 + 10 4.90 ± 0.39 1.40 ± 0.50 3.50 ± 0.90 71.4%
9 Castor oil + 4-AP + Loperamide 5 + 10 5 ± 1.73 1.31 ± 0.90 3.69 ± 0.45 73.8%
10 Castor oil + GB + Mc.Cr 3 + 150 5.83 ± 0.50 3.84 ± 0.37$ 1.99 ± 0.36 34.1%
11 Castor oil + 4-AP + Mc.Cr 5 + 150 6.11 ± 0.49$ 4.73 ± 0.31$$ 1.38 ± 0.41$ 22.5%
12 Castor oil + GB + Mc.Cr 3 + 300 5.56 ± 0.50$ 3.06 ± 0.57$$ 2.50 ± 0.62 44.9%
13 Castor oil + 4-AP + Mc.Cr 5 + 300 5.80 ± 0.46$$ 4.07 ± 0.57$$$ 1.73 ± 0.70$ 29.8%
p.o. (per oral), Values shown are mean ± S.E.M. of 6 determinations.
#p <0.05 and ###p <0.001 show a comparison of group #2 and 3 with group #1.
*p <0.05, **p <0.01 and ***p <0.001show a comparison of group # 4 and 5 with group #1.
$p <0.05, $$p <0.01 and $$$p <0.001 show a comparison of group # 6–13 with their respective treatments without GB or 4-AP (One-way ANOVA followed by
Dunnet’s test).
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1.8 vs. 84 ± 2.7, while it remained unaltered in the pres-
ence of 4-AP. However, loperamide did not show sensitiv-
ity to GB or 4-AP (Figure 1). All (Pi/Pm) × 1,000 values
are expressed as mean ± s.e.m. (n = 6).
Acute toxicity test
The plant extract was well tolerated by the animals up
to the tested oral dose of as high as 5 g/kg. No sign of
acute toxicity like restlessness, seizures and piloerection
was noticed over the period of observation (6 h) and there
was no death recorded up to 24 h.
In order to investigate the presence of gut relaxant
constitutes in Mc. Cr, which might be mediating its anti-
diarrhoeal and antisecretory activities, isolated rabbit je-
junum was selected for further studies.
Effect of Matricaria chamomillla on Rabbit Jejunum
The plant extract inhibited potently the spontaneous and
low K+-induced contractions with respective EC50 values
of 0.89 mg/ml (0.63-1.19, 95% CI, n = 5) and 0.77 mg/ml
(0.59-0.97, n = 7) compared to its effect (2.80 mg/ml (1.79-
3.21, n = 6) on high K+-induced contractions as shown
in Figure 2. When its effect on low K+-induced contrac-
tions was restudied in the presence glibenclamide (GB),
it was significantly inhibited with resultant EC50 value
of 3.09 mg/ml (2.21-3.76, n = 4) vs. 0.77 mg/ml (0.59-0.97,
n = 7). In the presence 4-aminopyridine (4-AP), the re-
laxant effect of Mc. Cr was almost blocked with remaining
maximum relaxation of only 29.73 ± 12.70% vs. 100%
(n = 4-5) at the highest tested concentration of 10 mg/ml
(Figure 3A).
Cromakalim also caused complete relaxation of low
K+ with an EC50 value of 0.92 μM (0.56-1.34, n = 5),
while it had negligible effect on high K+-induced con-
tractions, producing only 27.19 ± 7% (n = 4) relaxation
at the highest tested concentration of 10 μM. When its ef-
fect on low K+-induced contractions was studied in tissues
pretreated with GB, it was significantly inhibited with
remaining maximum relaxation of only 20.66 ± 4.29% vs.
Figure 1 Antidiarrhoeal and antisecretory effects of Matricaria
chamomilla in mice. The dose-dependent inhibitory effect of the
crude extract of Matricaria chamomilla (Mc. Cr) on castor oil-induced
fluid accumulation in the small intestine of mice, (A) without
and (B) with glibenclamide (GB) or 4-aminopyridine (4-AP). Intestinal
fluid accumulation is expressed as Pi/Pm × 1000, whereas Pi is
the weight of the small intestine and Pm is the weight (in g) of
the mouse. The values are mean ± s.e.m., n = 6. *p < 0.05, **p < 0.01
and ***p < 0.001 (Unpaired t-test or One-way ANOVA followed by
Dunnett’s test).
Figure 2 The concentration-response inhibitory curves of
the crude extract of Matricaria chamomilla (Mc. Cr) on
spontaneous, low K+ and high K+-induced contractions in
isolated rabbit jejunum preparations. The values shown are
mean ± s.e.m. from 5–7 determinations.
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100% (without GB) at the highest tested concentration
(10 μM). However, there was no significant change in the
relaxant effect of cromakalim [(1.10 μM (0.68-1.89, n = 5)
vs. 0.92 μM (0.56-1.34, n = 4)] when reproduced in the
presence of 4-AP, as shown in Figure 3B. Verapamil
caused relaxation of high K+ and low K+-induced con-
tractions at similar concentrations with respective EC50
values of 0.19 μM (0.12-0.28, n = 6) and 0.27 μM (0.20-
0.37, n = 5). However, the relaxant effect of verapamil on
low K+-induced contractions was found insensitive to GB
and 4-AP (Figure 3C).
The inhibitory effect of the plant extract was studied on
high K+-induced contractions, to confirm if it exhibits
Ca++ channel blockade-like activity at high doses. Inter-
estingly the plant extract caused a rightward shift in the
concentration response curves (CRCs) of Ca++ with the
suppression of the maximum response at 1 and 3 mg/ml,
respectively (Figure 4A). A positive control, verapamil
also produced a rightward shift in the CRCs of Ca++and
showed marked attenuation in the maximum response
of Ca++ at applied concentrations of 0.03 and 0.1 μM
(Figure 4B). Cromakalim was devoid of any effect in the
CRCs of Ca++ (Figure 4C) as expected.
Discussion
To validate the medicinal use of the crude extract of
Matricaria chamomilla in hyperactive gut disorders, like
diarrhoea and abdominal colic [1,6], this study was de-
signed to determine the antidiarrhoeal, antisecretory and
antispasmodic activities of the plant extract using the in-
vivo and in-vitro assays. To study the insight into mech-
anisms isolated rabbit jejunum preparations were used.
In castor oil-induced diarrhoea and intestinal fluid accu-
mulation models, Mc. Cr showed antidiarrhoeal and anti-
secretory activities at 150 and 300 mg/kg, similar to the
effects of cromakalim [38] and loperamide [39], which are
known for their spasmolytic, antidiarrhoeal and antisecre-
tory activities. Castor oil is known to cause increased in-
testinal fluid contents and promotes diarrhoea indirectly
through the effect of its active constituent, ricinoleic acid
formed by the hydrolysis of oil [40], which changes
the electrolytes and water transport [41] and generates
massive contractions in transverse and distal colon [42].
The observed antidiarrhoeal and antisecretory effects of
the plant extract appear to be mediated partly through
the involvement of potassium channels activation which
was evident by partial attenuation of these effects when
Figure 3 Antispasmodic effect of Matricaria chamomilla against low K+ (25 mM) contractions. Concentration-response inhibitory curves
showing comparison of (A) the crude extract of Matricaria chamomilla (Mc. Cr), (B) cromakalim and (C) verapamil in the absence and presences
of 10 μM glibenclamide (GB) or 1 mM 4-aminopyridine (4-AP) against low K+ (25 mM)-induced contractions in isolated rabbit jejunum preparations.
The values shown are mean ± s.e.m. from 4–6 determinations.
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reproduced in mice pretreated with glibenclamide
(GB), an ATP-dependent K+ channel blocker [34] or 4-
aminopyridine (4-AP), a voltage-dependent K+ channel
blocker [35], thus, indicating the presence of gut inhibi-
tory constituents in Mc. Cr which might me mediating its
observed antidiarrhoeal and antisecretory effects.
The role of multiple types of physiological mediators,
such as, acetylcholine, histamine, substance-P, cholecys-
tokinins, prostaglandins and 5-hydroxytryptamine [43]
and some ion channels like, K+ or Ca++, is well established
in regulatory function of gastrointestinal system. Further,
it has also been documented that most of the spasmolytic
agents have therapeutic potential in diarrhoea by causing
relaxation of the smooth muscle of the gut, in turn retain
luminal fluid in the bowl [38,44].
It has been observed that most of the plant and plant-
based test materials exhibit inhibitory effect through K+
channel activation or Ca++ channel blockade like mecha-
nisms [30-33,45,46]. The use of low K+ (25 mM) and high
K+ (80 mM)-induced depolarization in the tissues is usu-
ally carried out to distinguish K+ channel opening and
Ca++ channel blocking like activities [32,33]. On the basis
of presence of K+ channels and voltage dependent Ca++
channels in intestinal smooth muscles and epithelial cells
[46], K+ channel openers (increase in K+ efflux) and Ca++
antagonists (inhibition of Ca++ entry) cause smooth
muscle relaxation by decreasing intracellular free Ca++,
through respective mechanisms of membrane hyperpolar-
ization [38,44].
To assess whether the inhibitory effect of Mc. Cr was
also mediated via similar mechanisms, it was tested on
low and high K+-induced contractions in isolated rabbit
jejunum, where it caused complete relaxation of low and
high K+-induced contractions, being more potent against
low K+. Cromakalim, a known ATP-dependent K+-chan-
nel opener [38], inhibited only low K+-induced contrac-
tions, while verapamil, a known Ca++ antagonist [44],
was found equipotent against both low and high K+-in-
duced contractions. These data show that the presence
of spasmolytic constituents in Matricaria chamomilla, is
likely to be responsible for its observed antidiarrhoeal
and antisecretory activities in mice, mediating their ef-
fect primarily through K+ channel opening (KCO) along
with weak Ca++ channel blockade (CCB) component.
To know the nature of K+ channels involved in KCO
activity of Mc. Cr, the inhibitory CRCs of plant extract
Figure 4 Ca++ antagonist effect of Matricaria chamomilla
against CaCl2 contractions. The concentration-response curves
of Ca++ constructed in the absence and presence of increasing
concentration of (A) The crude extract of Matricaria chamomilla
(Mc. Cr), (B) verapamil and (C) cromakalim in isolated rabbit
jejunum preparations. The values shown are mean ± s.e.m. from
4–5 determinations.
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against low K+ were constructed in the absence and pres-
ence of GB or 4-AP. Interestingly, in line with in vivo find-
ings in mice, the inhibitory effect of Mc. Cr was potently
inhibited in the presence 4-AP compared to GB. This indi-
cates that the KCO activity of plant extract predominantly
involves voltage-dependent K+ channels along with
ATP-sensitive K+ channels, which are abundantly present
in intestinal smooth muscles and are also known for their
inhibitory influence in hypermotile gut [47].
The concentration of K+ > 30 mM, regarded as high K+,
is known to cause smooth muscle contractions through
opening of voltage-dependent Ca++ channels [36]. Thus, a
substance that inhibits high K+-provoked contractions is
considered a blocker of Ca++ influx [48]. The Ca++ antag-
onist effect was confirmed when Mc. Cr, at slightly higher
concentrations, shifted the CRCs of Ca++ to the right
with suppression of the maximum effect, a typical char-
acteristic of Ca++ antagonists [37], which are known for
their antispasmodic, antisecretory and antidiarrhoeal ac-
tivities [43,44]. These findings attest the presence of CCB-
like spasmolytic continents in Matricaria chamomilla in
addition to its primary effect as K+ channel opener. This
study are not only provides an evidence to the medicinal
use of Matricaria chemomilla in diarrhoea but also high-
lights the potential of this popular medicinal plant for the
development of newer therapeutic options to treat hyper-
active gut disorders, such as gut spasms and diarrhoea.
Conclusions
These findings indicate that Matricaria chamomilla pos-
sesses antidiarrhoeal, antisecretory and antispasmodic activ-
ities mediated predominantly through K+ channels activation
along with weak Ca++ channel antagonist like pathways,
thus, providing an evidence to the medicinal use of Matri-
caria chamomilla in abdominal colic and diarrhoea.
Abbreviations
Mc. Cr: Crude extract of Matricaria chamomilla; Low K+: K+ (25 mM);
High K+: K+ (80 mM); GB: Glibenclamide; 4-AP: 4-aminopyridine;
EC50: Effective concentration producing 50% effect; CI: Confidence
interval; ACh: Acetylcholine; CRCs: Concentration-response curves;
p.o.: Per oral; i.p: Intraperitoneally; KCO: K+ channel opening; CCB: Ca++
channel blockade.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MHM designed the project, supervised the study and drafted final
manuscript. SM and UAK carried out literature search, experimental work
and data acquisition. AHG contributed in study design and review of
the manuscript. MA identified and procured the plant material and
reviewed the manuscript for publication. All authors read and approved
the final manuscript for publication.
Authors’ information
MHM is an Assistant Professor at Natural Product Research Division,Department
of Biological and Biomedical Sciences, Faculty of Health Sciences, Medical
College, The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800,
Pakistan. SM and UAK are undergraduate medical students at Medical College,
The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan.
AHG is a Professor of Pharmacology at Natural Product Research Unit,
Department of Biological and Biomedical Sciences, The Aga Khan University
Medical College, Karachi-74800, Pakistan. MA is Professor at Department of Bot-
any, University of Balochistan, Quetta.
Acknowledgement
The study was carried out during Research Module of the Undergraduate
Students. The financial support was provided to Dr. Malik Hassan Mehmood
from the Department of Biological and Biomedical Sciences, The Aga Khan
University.
Author details
1Natural Product Research Division, Department of Biological and Biomedical
Sciences, Faculty of Health Sciences, Medical College, The Aga Khan
University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan.
2Department of Botany, University of Balochistan, Quetta, Pakistan.
Received: 29 April 2014 Accepted: 28 February 2015
References
1. Grieve M, Leyel CF. The medicinal, culinary, cosmetic and economic
properties, cultivation and folklore of herbs, grasses, fungi, shrubs and trees
with all their modern scientific uses. In: A modern herbal. Tiger books
International, Mackays of Chatham, PLC, Chatham, Kent; 1994, pp. 961–962.
2. Ahmad S, Koukab S, Razzaq N, Islam M, Rose A, Aslam M. Cultivation of
Matricaria recutita L. in highlands of Balochistan, Pakistan. Pakistan J Agric
Res. 2011;24:35–41.
3. Ali SI, Qaiser M. Flora of Pakistan (No. 207) Asteraceae (1) Anthemideae by
Abdul Ghafoor. Botany Department University Karachi; 2002, 172.
4. Duke JA, Bogenschutz-Godwin MJ, Du Celliar J, Duke PAK. Plantago
ovata F. In: Hand book of medicinal herbs. 2nd ed. Boca Raton: CRC
Press; 2002. p. 174–5.
5. Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria
chamomilla L.): an overview. Pharmacogn Rev. 2011;5:82–95.
6. Nadkarni KM: 1986. Indian Materia Medica. 3rd revised and enlarged ed.,
Popular Prakashan, Bombay; 1986, 772.
7. de la Motte S, Bose-O’Reilly S, Heinisch M, Harrison F. Double-blind comparison
of an apple pectin-chamomile extract preparation with placebo in children
with diarrhoea. Arzneimittelforschung. 1997;47:1247–9.
8. Weizman Z, Alkrinawi S, Goldfarb D, Bitran C. Efficacy of herbal tea
preparation in infantile colic. J Pediatr. 1993;122:650–2.
9. World Health Organization. WHO monographs on selected medicinal plants,
vol. 1. Geneva: World Health Organization; 1999.
10. Baquar SR. Matricaria chamomilla L. In: Medicinal and poisonous plants of
Pakistan. Karachi, Pakistan: Printas Karachi; 1989. p. 278.
11. Issac O. Recent progress in chamomile research- medicines of plant origin
in modern therapy. 1st ed. Czecho-Slovakia: Prague press; 1989.
12. Das M, Mallavarapu GR, Kumar S. Chamomile (Chamomilla recutita):
economic botany, biology, chemistry, domestication and cultivation. J Med
Aromat Plant Sci. 1998;20:1074–109.
13. Kumar S, Das M, Singh A, Ram G, Mallavarapu GR, Ramesh S. J Med Aromat
Plant Sci. 2001;23:617–23.
14. Lawrence BM. Progress in essential oils. Perfume Flavorist. 1987;12:35–52.
15. Mann C, Staba EJ. The chemistry, pharmacology and commercial
formulations of chamomile. In: Craker LE, Simon JE, editors. Herbs, spices
and medicinal plants- recent advances in botany, horticulture and
pharmacology. Phoenix: Oryx Press; 1986. p. 235–80.
16. Schilcher H, Imming P, Goeters S. Active chemical constituents of Matricaria
chamomilla L. syn. Chamomilla recutita L. Rauschert. In: Franke R, Schilcher H,
editors. Chamomile-industrial profiles. Boca Raton: CRC Press; 2005. p. 55–76.
17. Kunde R, Isaac O. On the flavones of chamomile (Matricaria chamomilla L.)
and a new acetylated apigenin-7-glucoside. Planta Med. 1980;37:124–30.
18. Petruľová-Poracká V, Repčák M, Vilková M, Imrich J. Coumarins of Matricaria
chamomilla L.: aglycones and glycosides. Food Chem. 2013;141:54–9.
19. European Pharmacopoeia. 5th ed. Strasbourg, France: European directorate
for the quality of medicines of the council of Europe; 1996, 1976-1977.
20. Mazokopakis EE, Vrentzos GE, Papadakis JA, Babalis DE, Ganotakis ES. Wild
chamomile (Matricaria recutita L) mouthwashes in methotrexate-induced
oral mucositis. Phytomedicine. 2005;12:25–7.
Mehmood et al. BMC Complementary and Alternative Medicine  (2015) 15:75 Page 8 of 9
21. Maschi O, Cero ED, Galli GV, Caruso D, Bosisio E, Dell' Agli M. Inhibition of
human cAMP-phosphodiesterase as a mechanism of the spasmolytic effect
of Matricaria recutita L. J Agric Food Chem. 2008;56:5015–20.
22. Achterrath-Tuckermann U, Kunde R, Flaskamp E. Pharmacological
investigations with compounds of chamomile. V. Investigations on the
spasmolytic effect of compounds of chamomile and Kamillosan on the
isolated guinea pig ileum. Planta Med. 1980;39:38–50.
23. Shikov AN, Pozharitskaya ON, Makarov VG, Kvetnaya AS. Antibacterial activity
of Chamomilla recutita oil extract against Helicobacter pylori. Phytother Res.
2008;22:252–3.
24. Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA, Nash RJ. Protective
effects of dietary chamomile tea on diabetic complications. J Agric Food
Chem. 2008;56:8206–11.
25. Cemek M, Kaga S, Simsek N, Buyukokuroglu ME, Konuk M.
Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in
streptozotocin-induced diabetic rats. J Nat Med. 2008;62:284–93.
26. Asadi-Shahmirzadi A, Mozaffari S, Sanei Y, Baeeri M, Hajiaghaee R,
Monsef-Esfahani HR, et al. Benefit of Aloe vera and Matricaria recutita
mixture in rat irritable bowel syndrome: Combination of antioxidant
and spasmolytic effects. Chin J Integr Med. 2012; Dec 21. [Epub ahead
of print]
27. Williamson EM, Okpako DT, Evans FJ. Pharmacological methods in
phytotherapy research. Chichester: John Wiley& Sons; 1998. p. 15–23.
28. National Research Council. Guide for the care and use of laboratory animals.
Washington: National Academy Press; 1996. p. 1–7.
29. Umer S, Tekewe A, Kebede N. Antidiarrhoeal and antimicrobial activity of
Calpurnia aurea leaf extract. BMC Complement Altern Med. 2013;13:21.
30. Mehmood MH, Aziz N, Ghayur MN, Gilani AH. Pharmacological basis for the
medicinal use of Psyllium husk (Ispaghula) in constipation and diarrhoea.
Dig Dis Sci. 2010;56:1460–71.
31. Mehmood MH, Gilani AH. Pharmacological basis for the medicinal use of
black pepper and piperine in gastrointestinal disorders. J Med Food.
2010;13:1086–96.
32. Gilani AH, Mehmood MH, Janbaz KH, Khan A, Saeed SA.
Ethnopharmacological studies on antispasmodic and antiplatelet activities
of Ficus carica. J Ethnopharmacol. 2008;119:1–5.
33. Mehmood MH, Siddiqi HS, Gilani AH. The antidiarrhoeal and spasmolytic
activities of Phyllanthus emblica Linn. are mediated through dual
blockade of muscarinic receptors and Calcium channels. J Ethnopharmacol.
2011;133:856–65.
34. Frank H, Puschmann A, Schusdziarra V, Allescher HD. Functional evidence
for a glibenclamide-sensitive K+ channel in rat ileal smooth muscle. Eur J
Pharmacol. 1994;271:379–86.
35. Satake N, Shibata M, Shibata S. The inhibitory effects of iberiotoxin and
4-aminopyridine on the relaxation induced by beta1- and beta2-adrenoceptor
activation in rat aortic rings. Br J Pharmacol. 1996;119:505–10.
36. Farre AJ, Colombo M, Fort M, Gutierrez B. Differential effects of various Ca++
antagonists. Gen Pharmacol. 1991;22:177–81.
37. Van-Rossum JM. Cumulative concentration-response curves. II. Techniques
for the making of concentration-response curves in isolated organs and the
evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330.
38. Poggioli R, Benelli A, Arletti R, Cavazzuti E, Bertolini A. K+ channel openers
delay intestinal transit and have antidiarrhoeal activity. Eur J Pharmacol.
1995;287:207–9.
39. Reynolds IJ, Gould RJ, Snyder SH. Loperamide: blockade of calcium channels
as a mechanism for antidiarrhoeal effects. J Pharmacol Exp Ther.
1984;231:628–32.
40. Iwao I, Terada Y. On the mechanism of diarrhoea due to castor oil. Japanese
J Pharmacol. 1962;12:137–45.
41. Gaginella TS, Phillips SF. Ricinoleic acid: current view of ancient oi. Dig
DisSc. 1975;20:1171–7.
42. Croci T, Landi M, Elmonds X, Le-Fur G, Maffrand JP, Manara L. Role of
tachykinins in castor oil induced diarrhoea in rats. Br J Pharmacol.
1997;121:375–80.
43. Pasricha PJ. Goodman’s and Gilman’s: treatment of disorders of bowel
motility and water flux- the pharmacological basis of therapeutics. 11th ed.
New York: McGraw-Hill; 2006. p. 983–1008.
44. Lee CW, Sarna SK, Singaram C, Casper MA. Ca++ channel blockade by
verapamil inhibits GMCs and diarrhoea during small intestinal inflammation.
Am J Physiol. 1997;273:785–94.
45. Khan A, Najeeb-ur- Rehman, Al-Taweel AM, Perveen S, Fawzy GA, Gilani AH.
Studies on prokinetic, laxative, antidiarrhoeal and gut modulatory activities
of the aqueous-methanol extract of Celtis africana and underlying
mechanisms. Int J Pharmacol. 2012;8:701–7.
46. Khan A, Rehman NU, AlKharfy KM, Gilani AH. Antidiarrhoeal and
antispasmodic activities of Salvia officinalis are mediated through activation
of K+ channels. Bangladesh J Pharmacol. 2011;6:110–6.
47. Vogalis F. Potassium channels in gastrointestinal smooth muscle. J Auton
Pharmacol. 2000;20:207–19.
48. Chaudhary MA, Imran I, Bashir S, Mehmood MH, Rehman NU, Gilani AH.
Evaluation of gut modulatory and bronchodilator activities of Amaranthus
spinosus Linn. BMC Complement Altern Med. 2012;12:166.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mehmood et al. BMC Complementary and Alternative Medicine  (2015) 15:75 Page 9 of 9
